https://orcid.org/0000-0003-2080-0868
References
- Baccarelli A , ReinstraM , BenjaminEJ. Cardiovascular epigenetics: basic concepts and results from animal and human studies. Circ. Cardiovasc. Genet.3(6), 567–573 (2010).
- Malhotra R , MauerA , LinoCardenas CLet al. HDAC9 is implicated in atherosclerotic aortic calcification and affects vascular smooth muscle cell phenotype. Nat. Genet.51, 1580–1587 (2019).
- Potus F , PauciuloMW , CookEKet al. Novel mutations and decreased expression of the epigenetic regulator TET2 in pulmonary arterial hypertension. Circulation141, 1986–2000 (2020).
- Wong WJ , EmdinC , BickAGet al. Clonal haematopoiesis and risk of chronic liver disease. Nature616, 747–754 (2023).
- Farina FM , SerioS , HallIFet al. The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-kB pathway. Eur. Heart J.43(14), 4562–4576 (2022).
- Westerman K , SebastianiP , JacquesP , LiuS , DeMeoD , OrdovasJM. DNA methylation modules associate with incident cardiovascular disease and cumulative risk factor exposure. Clin Epigenetics11(142), (2019).
- Roselli C , YuM , NauffalVet al. Genome-wide association study reveals novel genetic loci: a new polygenic risk score for mitral valve prolapse. Eur. Heart J.43(17), 1668–1680 (2022).
- Shi Y , ZhangH , HuangSet al. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct. Target. Ther.7(200), (2022).
- Nuotio M , TahtisaloHS , LahtinenAet al. Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study design. Epigenetics17(11), 1432–1447 (2022).
- Ray KK , NichollsSJ , BuhrKAet al. Effect of apabetalone added to standard therapy on major adverse cardiovascular events in patients with recent acute coronary syndrome and type 2 diabetes: a randomized clinical trial. JAMA323(16), 1565–1573 (2020).
- Xie M , KongY , TanWet al. HDAC inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation129(10), 1139–1151 (2014).
- Napoli C , CrudeleV , SoricelliAet al. Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms. Circulation125(19), 2363–2373 (2012).
- Napoli C , CoscioniE , NigrisF , DonatelliF. Emergent expansion of clinical epigenetics in patients with cardiovascular diseases. Curr. Opin. Cardiol.36(3), 295–300 (2021).
- Aghagoli G , DelRe A , YanoNet al. Methylome of skeletal muscle tissue in patients with hypertension and diabetes undergoing cardiopulmonary bypass. Epigenomics13(23), (2021).
- Fischer MA , ChapskiDJ , SoehalimEet al. Longitudinal profiling in patients undergoing cardiac surgery reveals postoperative changes in DNA methylation. Clin. Epigenetics14(195),(2022).
- Fischer MA , MahajanA , CabajM , KimballTet al. DNA methylation-based prediction of postoperative atrial fibrillation. Front. Cardiovasc. Med.9, (2022).
- Kashani RG , SarehS , GenoveseBet al. Predicting postoperative atrial fibrillation using CHA2DS2-VASc scores. J. Surg. Res.198(2), 267–272 (2015).
- Kolek MJ , MuehlschlegelJD , BushWSet al. Circ. Arrhythm. Electrophysiol. 8(1), 25–31 (2016).
- Sabia C , PicasciaA , GrimaldiV , AmarelliC , MaielloC , NapoliC. The epigenetic promise to improve prognosis of heart failure and heart transplantation. Transplant. Rev. (Orlando)31(4), 249–256 (2017).
- Chen X , JiangD , XuLet al. Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women. Exp. Ther. Med.17, 205–213 (2019).
- Napoli C , BenincasaG , DonatelliF , AmbrosioG. Precision medicine in distinct heart failure phenotypes: focus on clinical epigenetics. Am. Heart J.224, 113–128 (2020).
- Mansueto G , BenincasaG , MuraND , NicolettiGF , NapoliC. Epigenetic-sensitive liquid biomarkers and personalized therapy in advanced failure: a focus on cell-free DNA and microRNAs. J. Clin. Pathol.73(9), 535–543 (2020).